Ilan Zipkin

Founder and Ceo

Supercede Therapeutics Inc. · San Francisco Bay Area

Present

Venture Partner

Breakout Ventures · San Francisco, California, United States

Present

Partner and Vp, Business Development and Licensing

Aditum Bio · San Francisco Bay Area

In-licensing and clinical development of therapeutics to enable improved patient access

Founder and Managing Partner

Supercede Ventures · San Francisco Bay Area

Biotechnology startup strategy, advisory, and investing

Vice President, Business Development

Parker Institute for Cancer Immunotherapy · San Francisco, CA

The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort. The Parker Institute is an unprecedented collaboration between the country’s leading immunologists and cancer centers, including Memorial Sloan Kettering Cancer Center, Stanford Medicine, the University of California, Los Angeles, the University of California, San Francisco, the University of Pennsylvania and The University of Texas MD Anderson Cancer Center. The Parker Institute network also includes more than 40 industry and nonprofit partners, more than 60 labs and more than 300 of the nation’s top researchers focused on treating the deadliest cancers. The goal is to accelerate the development of breakthrough immune therapies capable of turning most cancers into curable diseases.

Senior Investment Director

Takeda Ventures, Inc. · Palo Alto, CA

Takeda Ventures Inc. uses capital investment to nuture early stage innovation and create access to novel, emerging biotechnology product and business opportunities that enable Takeda Pharmaceuticals' goal of becoming a leading, innovation-driven, global health care provider.

Partner

Prospect Venture Partners

Associate - Partner

MPM Capital · South San Francisco, CA

Science Editor

BioCentury Publications · Belmont, CA